health_text_en | Page 32 of 73

Triastek announces research collaboration with Lilly to explore the application of 3D printing technology in oral delivery of drugs

On July 13, 2022, Triastek, Inc. (“Triastek”) announced a collaboration with Eli Lilly and Company (“Lilly”), a leading global pharmaceutical company, to leverage the advantages of 3D printing technology to enable precisely targeted and programmed release of drugs in specific regions of the GI tract. According to the agreement, the project will focus on the […]

14 ก.ค. 65 9:30

thaipr.net

14 ก.ค. 65

Discovery Life Sciences Acquires AllCells

CREATES PREMIER GLOBAL PROVIDER OF CRITICAL STARTING MATERIALS AND ANALYTIC SERVICES TO ACCELERATE CELL AND GENE THERAPY APPLICATIONS Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, today announced its acquisition of AllCells®, a leading provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products. With more than 30 years of collective cell and […]

14 ก.ค. 65 8:30

thaipr.net

14 ก.ค. 65

Sport’s finest gather under the stars for the grand finale of the XXVI Fair Play Menarini International Award

Intense emotions and immense satisfaction were in the air during the final event of the XXVI Fair Play Menarini International Award. Yesterday evening, the award ceremony for the winners of the 2022 edition in Castiglion Fiorentino (Arezzo) drew an enjoyable end to this celebration of the values of sportsmanship, organised by the Fair Play Menarini Foundation. Ethics, loyalty and […]

11 ก.ค. 65 10:26

thaipr.net

11 ก.ค. 65

JW Therapeutics Announces Initiation of Clinical Study of JWATM204 in Patients with Advanced Hepatocellular Carcinoma

JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the initiation of phase I clinical study of JWATM204 in patients with advanced hepatocellular carcinoma (HCC). Primary liver cancer (PLC), also known as liver carcinoma, is one of the common gastrointestinal malignancies worldwide. Approximately 85%-90% […]

5 ก.ค. 65 8:00

thaipr.net

5 ก.ค. 65

Octapharma shares new data at ISTH 2022 in its mission to meet the challenges faced by people with bleeding disorders

Octapharma to present new clinical and scientific data from across Octapharma’s haematology and critical care portfolios during the ISTH 2022 Congress Data to be presented in 11 poster presentations and during two Supported Symposia New data from the extensive clinical trial programme with Nuwiq® (simoctocog alfa) to be presented, confirming Nuwiq®‘s efficacy and safety profile The […]

4 ก.ค. 65 17:00

thaipr.net

4 ก.ค. 65

NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe

– Combines NewAmsterdam’s lead clinical program obicetrapib with Menarini’s deep cardiovascular disease and regional expertise – Total deal value of over €1 billion; including €142.5 million upfront payment and committed R&D funding plus potential milestones and double-digit royalties on net product sales in Europe – Obicetrapib is a next-generation oral, low-dose and once-daily CETP inhibitor for […]

29 มิ.ย. 65 17:16

thaipr.net

29 มิ.ย. 65

Amai Proteins, producer of 100% protein sweetener that reduces sugar in Food & Beverages by up to 70%, voted Global Winner at the 2022 Extreme Tech Challenge Competition

Amai Proteins, an Israeli start-up developer of novel designer proteins that answer the needs of consumers and industry, is the Global Winner of the 2022 XTC competition. Extreme Tech Challenge (XTC) is the world’s largest start-up competition for purpose-driven companies. Over 2000+ start-ups from 100+ countries competed in 10 impact areas ranging from Biotech to […]

29 มิ.ย. 65 8:30

thaipr.net

29 มิ.ย. 65

JOYSBIO offers SARS-COV-2 Antigen Rapid Test that detects Omicron subvariants BA.4 and BA.5

As the SARS-COV-2 Omicron subvariants BA.4 and BA.5 make their way across the EU and the US, Joysbio is able to give people the power to administer a rapid test for themselves at home. The Joysbio Coronavirus Antigen Rapid Test Kit can effectively detect the Omicron subvariants BA.4 and BA.5. The test is certified by […]

27 มิ.ย. 65 14:30

thaipr.net

27 มิ.ย. 65

Abcam: Appointment of Vice President of Investor Relations

Abcam plc (“Abcam,” “Company,” “Group”) (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment of Tommy Thomas as Vice President of Investor Relations. Tommy, who will be based in our Waltham, MA office, has over 20 years’ experience in the life sciences sector, largely focused in […]

27 มิ.ย. 65 13:30

thaipr.net

27 มิ.ย. 65

EAN Congress 2022: COVID-19 positive patients at higher risk of developing neurodegenerative disorders, new study shows

COVID-19 positive outpatients are at an increased risk of neurodegenerative disorders compared with individuals who tested negative for the virus, a new study presented today at the 8th European Academy of Neurology (EAN) Congress has shown. The study, which analysed the health records of over half of the Danish population, found that those who had tested […]

27 มิ.ย. 65 8:10

thaipr.net

27 มิ.ย. 65